Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes

Fig. 5

Gut mycobiome-based classification of the ESRD patients and healthy controls. A Random forest model for discriminating patients and controls based on gut fungal profiles at the species levels. The area under the receiver-operating characteristic curve (AUC) and 95% confidence interval (CI) are shown. B Mean decrease in accuracy of the most 15 important fungal species in the random forest model

Back to article page